Swedbank Robur Healthcare
- Namn
- Swedbank Robur Healthcare
- Fondbolag
- Swedbank Robur Fonder AB
- ISIN
- SE0000639445
- Kvartalsslut
- Fondförmögenhet
- 17 241 941 196 SEK
- Likvida medel
- 819 915 632 SEK
- Övriga tillgångar och skulder
- 39 009 625 SEK
- Antal innehav
- 58
- Aktiv risk
- 4,18
- Standardavvikelse 24 månader
- 11,23
- Jämförelseindex
- MSCI World Health Care 10/40 Net
-
Förvaltningsavgift
Healthcare A - 1,25% Fast
-
Förvaltningsavgift
Healthcare C - 1,25% Fast
Största innehav
| Namn | Marknadsvärde | Andel av fondförmögenhet | Bransch |
|---|---|---|---|
| United Health | 1 619 146 738 SEK | 9,39% | Health Care |
| Thermo Fisher Scientific | 926 253 515 SEK | 5,37% | Health Care |
| AstraZeneca | 925 335 774 SEK | 5,37% | Health Care |
| Roche | 911 091 216 SEK | 5,28% | Health Care |
| Merck | 802 190 355 SEK | 4,65% | Health Care |
| Eli Lilly | 774 847 554 SEK | 4,49% | Health Care |
| Centene | 754 365 234 SEK | 4,38% | Health Care |
| Abbott Laboratories | 756 057 592 SEK | 4,38% | Health Care |
| AbbVie | 701 280 215 SEK | 4,07% | Health Care |
| Pfizer | 649 004 976 SEK | 3,76% | Health Care |
| Sanofi | 537 612 188 SEK | 3,12% | Health Care |
| Vertex Pharmaceuticals | 537 561 048 SEK | 3,12% | Health Care |
| Novo Nordisk | 508 701 359 SEK | 2,95% | Health Care |
| Amgen | 502 652 223 SEK | 2,92% | Health Care |
| McKesson | 406 767 491 SEK | 2,36% | Health Care |
| Boston Scientific | 371 277 153 SEK | 2,15% | Health Care |
| Edward Lifesciences | 333 120 220 SEK | 1,93% | Health Care |
| Cooper Companies | 317 379 695 SEK | 1,84% | Health Care |
| Horizon Therapeutics | 316 222 494 SEK | 1,83% | Health Care |
| Takeda | 309 807 379 SEK | 1,80% | Health Care |
| BioArctic | 286 706 964 SEK | 1,66% | Health Care |
| Royalty Pharma | 254 209 221 SEK | 1,47% | Health Care |
| Halozyme Therapeutics | 251 665 520 SEK | 1,46% | Health Care |
| IQVIA | 198 932 238 SEK | 1,15% | Health Care |
| Hologic | 171 470 473 SEK | 0,99% | Health Care |
Branscher
Källa: Finansinspektionen.